The genetic background of medullary thyroid carcinoma in young patients. 2001

M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice, Poland.

The study was undertaken to evaluate the frequency of RET polymorphisms at codons 769 and 836 in young medullary thyroid carcinoma (MTC) patients in whom the presence of a known germline mutation has been excluded. 40 patients aged 10-29 were subjected to genetic analysis of RET exons 10, 11, 13, 14 and 16 and compared to 140 older patients. The hereditary component occurred to be very high in young MTC patients: 57% carry the germline mutation, other 28% exhibit at least one rare polymorphic variant of RET. The observed allelic frequencies were 38% for polymorphic variant L769CTG and 6% for variant S836AGT. The results were significantly higher than those obtained in the group of older patients: 20% and 1% for L769CTG and S836AGT, respectively. Our results speak in favour that the polymorphism in RET codon 769 and 836 may also be a factor predisposing to the development of MTC in young age.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm

Related Publications

M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
April 2016, Oncotarget,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
July 2007, Arquivos brasileiros de endocrinologia e metabologia,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
October 1986, World journal of surgery,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
January 1993, The Clinical investigator,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
January 2003, Acta chirurgica Iugoslavica,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
January 1992, Henry Ford Hospital medical journal,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
January 1996, Journal of the Royal College of Physicians of London,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
January 1994, Current therapy in endocrinology and metabolism,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
June 2004, Acta oto-laryngologica,
M Wiench, and Z Wygoda, and E Gubała, and J Włoch, and M Oczko, and B Jarzab
January 1993, The British journal of surgery,
Copied contents to your clipboard!